Introduction
Histoplasmosis is known to occur in sub-Saharan Africa but is rarely diagnosed. In settings with limited laboratory capacity, histoplasmosis may be difficult to distinguish from diseases with similar clinical features, such as tuberculosis and bacterial pneumonia. While Histoplasmosis capsulatum var. duboisii (H. duboisii) appears to occur more often in west Africa and Histoplasmosis capsulatum var. capsulatum (H. capsulatum) predominates in southern Africa, both varieties have been documented to cause human infection in East Africa. 1 In Tanzania, H. duboisii has been isolated from environmental samples 2 and H. capsulatum has been reported to cause human disease in the coastal areas around the cities of Tanga 3 and Dar es Salaam, 1 and has been documented in a Tanzanian expatriate. 4 We report nine human cases of histoplasmosis from northern Tanzania identified by urine or serum antigen testing and highlight the challenge in clinical diagnosis of histoplasmosis in areas with limited laboratory capacity. 15 Medical Centre and Mawenzi Regional Hospital in Moshi, Tanzania, as part of a study to characterize the etiology of febrile illness. 5, 6 A standardized clinical history and physical examination was done by a member of the research team. Among other diagnostic samples, blood cultures, acute urine, and acute and convalescent serum were collected. After completion of study enrollment and follow up, acute urine and serum samples that had been frozen at −80 • C and transported on dry ice were tested retrospectively for Histoplasma antigen using a sandwich enzyme immunoassay (EIA) using polyclonal antibodies to H. capsulatum (the MVista Histoplasma capsulatum Quantitative Antigen EIA; Miravista Diagnostics, Indianapolis, IN, USA). Serum specimens were treated with ethylene diamine tetraacetic acid at 104 • C before testing for antigen. 7 Specimens yielding a result above the cutoff were regarded as positive. 8, 9 All positive results were confirmed by repeat testing. A case of probable histoplasmosis was defined as a patient with Histoplasma antigen test result from detectable <0.6 ng to >39.0. 9
Materials and methods

From
Results
Of 870 patients enrolled, 628 (72.2%) patients had urine available for Histoplasma urine antigen testing. Of these, 7 (1.1%) were found to be positive with concentrations ranging from <0.6 to >39.0 ng/mL. Of these with Histoplasma antigenuria, 4 also had serum available for testing and 2 (50%) of these also had detectable Histoplasma antigen in their serum. Of those who had urine tested an additional 200 patients (100 pediatric and 100 adult) had acute serum tested for Histoplasma antigen. From these samples 2 additional patients were found to have serum positive for Histoplasma antigen. In total, 9 (0.9%) patients met the definition of probable histoplasmosis. All results were confirmed positive on repeat testing. No patient had a positive blood culture for H. capsulatum (Table 1) . Histoplasma testing was done 6-18 months after sample collection. Once available, results were provided to the clinical team.
Discussion
We demonstrate that Histoplasma is an etiologic agent of fever among inpatients with and without HIV infection in northern Tanzania. 5, 6 However, histoplasmosis was not considered in the differential diagnosis by clinicians and without the laboratory capacity to support histoplasmosis diagnosis, patients with probable histoplasmosis were often diagnosed clinically with tuberculosis, bacterial pneumonia, or malaria. The majority of patients with histoplasmosis were treated for other causes of disease based on perceptions of common etiologies for clinical syndromes. Improved awareness of the presence of histoplasmosis may lead to incorporation of the infection in differential diagnosis, particularly among persons not responding to empiric treatment for tuberculosis, community-acquired pneumonia, and malaria.
The diagnosis of histoplasmosis in this study was by antigen testing. While we collected blood cultures on all participants, blood culture techniques that would reliably detect Histoplasma fungemia 10 were only used among adults and adolescents. In all cases Histoplasma antigen testing was reproducibly positive. The sensitivity of the Histoplasma antigen test among HIV-infected patients is 100% in urine and 92.3% in serum, and the specificity of both is 99% among controls. 7, 9 Detection of antigen is a basis for a probable diagnosis of histoplasmosis in patients with compatible clinical findings. 11 While it is uncertain whether our patients had H. capsulatum or H. duboisii, as the antigen detected in both mycoses is cross reactive, 12 clinical features and other case series done in East Africa suggest that H. capsulatum is likely to predominate. 3 Although Histoplasma has been isolated from patient samples in Tanzania in the past, 13 none of the patients reported in our series had positive fungal cultures. Consequently, the diagnosis of probable histoplasmosis relied on the combination of antigen detection and clinical features. Future research should focus on identifying culture-confirmed histoplasmosis to allow validation of non-culture diagnostic techniques in the sub-Saharan Africa setting. Adaptation and validation of Histoplasma antigen tests for use in low resource settings could assist with recognition of patients with the infection. 14 In conclusion, histoplasmosis is a cause of fever among inpatients in northern Tanzania but is rarely considered by clinicians in settings with limited laboratory capacity. Patients with histoplasmosis often receive a clinical diagnosis of tuberculosis, bacterial pneumonia or malaria leading to inappropriate treatment. Improved access to diagnostic tests for histoplasmosis, including the development of an appropriately validated simple Histoplasma antigen test suitable for use in low-and middle-income countries where histoplasmosis is endemic may improve patient outcomes.
Funding: This research was supported by an International
